Clinical Significance of Human Herpesvirus 6 Positivity on the FilmArray Meningitis/Encephalitis Panel
Open accessThe DOI matches its Crossref record; 13 of the 24 references it cites were found in a registry or an index.
Abstract
A review of 15 patients who tested positive for human herpesvirus 6 (HHV-6) on the FilmArray Meningitis/Encephalitis panel revealed that the majority were unlikely to have HHV-6 encephalitis. Criteria to assist interpretation of HHV-6 positive results are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, pre-analytic factors also need to be considered prior to interpretation of viral load, including WCC count, which can significantly elevate levels (9).”
From A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, HHV‐6 may become integrated into host chromosomal DNA and transmitted vertically, producing sustained PCR detection that does not necessarily indicate clinical infection [21].”
From Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This means that only 0.1–0.3% of the whole study population and 6.66% to 20% of the HHV-6-positive cohort had HHV-6 meningitis.”
From Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? (2024) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is higher than what is written in the literature (0.1% to 2.20% of the total study populations and 6% to 36% of the HHV-6-positive CSF samples).”
From Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? (2024) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In our study, of the 100 patients who had a meningitis/encephalitis panel performed, 5 had HHV-6 DNA detectable in their CSF (5%), which is consistent with what we found in the literature (ranging from 1.9% to 11.45%).”
From Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? (2024) · cites this paper as [19]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Zerr, D. M., Corey, L., Kim, H. W., Huang, M., Nguy, L., & Boeckh, M. (2005) · Clinical Infectious Diseases · doi:10.1086/428060 · Cited by 338 · cited 2×
“First, the patient was an HSCT recipient and had received her transplant 3 weeks before symptom onset; HHV-6 encephalitis is well described in this patient population 2–6 weeks after transplant [3, 4].”
BackgroundPost-transplant acute limbic encephalitis: Clinical features and relationship to HHV6
Seeley, W. W., Marty, F. M., Holmes, T. M., Upchurch, K., Soiffer, R. J., Antin, J. H., Baden, L. R., & Bromfield, E. B. (2007) · Neurology · doi:10.1212/01.wnl.0000265591.10200.d7 · Cited by 284
Nam Leong, H., Tuke, P. W., Tedder, R. S., Khanom, A. B., Eglin, R. P., Atkinson, C. E., Ward, K. N., Griffiths, P. D., & Clark, D. A. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20760 · Cited by 212 · cited 1×
“Viral nucleic acids can also be detected in other host-virus states, such as latency, asymptomatic viral reactivation, and chromosomal integration, the latter phenomenon occurring in about 1% of the population [1, 2].”
BackgroundZerr, D. M., Gupta, D., Huang, M.-L., Carter, R., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/338044 · Cited by 202 · cited 1×
“Studies have shown a wide range of CSF viral loads from 600–600 000 copies/mL among HSCT recipients with HHV-6 encephalitis, with a median of about 11 000–16 000 copies/mL [3, 11, 12].”
BackgroundHall, C. B., Caserta, M. T., Schnabel, K., Shelley, L. M., Marino, A. S., Carnahan, J. A., Yoo, C., Lofthus, G. K., & McDermott, M. P. (2008) · Pediatrics · doi:10.1542/peds.2007-2838 · Cited by 196 · cited 1×
“Viral nucleic acids can also be detected in other host-virus states, such as latency, asymptomatic viral reactivation, and chromosomal integration, the latter phenomenon occurring in about 1% of the population [1, 2].”
BackgroundOgata, M., Satou, T., Kadota, J.-I., Saito, N., Yoshida, T., Okumura, H., Ueki, T., Nagafuji, K., Kako, S., Uoshima, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit358 · Cited by 196 · cited 4×
“Studies have shown a wide range of CSF viral loads from 600–600 000 copies/mL among HSCT recipients with HHV-6 encephalitis, with a median of about 11 000–16 000 copies/mL [3, 11, 12].”
BackgroundInfluentialHuman herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation
Zerr, D. M. (2006) · Journal of Clinical Virology · doi:10.1016/s1386-6532(06)70012-9 · Cited by 157 · cited 1×
“Memory loss, confusion, and depressed consciousness are common initial symptoms [9, 10], with overt seizures occurring in about 40%–70% of patients [8].”
BackgroundOgata, M., Fukuda, T., & Teshima, T. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.76 · Cited by 133 · cited 2×
“Nevertheless, many patients with uncertain diagnoses may still warrant early antiviral therapy, because HHV-6 encephalitis can progress rapidly, with potentially devastating consequences [8].”
BackgroundRazonable, R. R., Fanning, C., Brown, R. A., Espy, M. J., Rivero, A., Wilson, J. A., Kremers, W. K., Smith, T. F. A., & Payá, C. V. (2002) · The Journal of Infectious Diseases · doi:10.1086/324772 · Cited by 125 · cited 1×
“In 1 study, HHV-6 reactivation was demonstrated in 54 of 101 critically ill patients (53%) admitted to the intensive care unit, compared with 0 of 50 healthy volunteers (0%) [7].”
Reddy, S., & Manna, P. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.04.010 · Cited by 55 · cited 1×
“Studies have shown a wide range of CSF viral loads from 600–600 000 copies/mL among HSCT recipients with HHV-6 encephalitis, with a median of about 11 000–16 000 copies/mL [3, 11, 12].”
Background
Cited by
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Radmard, S., Reid, S., Ciryam, P., Boubour, A., Ho, N., Zucker, J., Sayre, D., Greendyke, W. G., Miko, B. A., Pereira, M. R., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00281 · Cited by 127
“These included three HHV-6 cases and oneHSV-2 case (28).”
BackgroundResultInfluentialSelf-citationMadan, R. P., Hand, J. M., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13518 · Cited by 107
Panels and syndromic testing in clinical microbiology
Dien Bard, J., & McElvania, E. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.08.001 · Cited by 92
“infection supporting the need for potential test restrictions in patients with clear index of suspicion for central nervous system infections.(28) CSF testing restriction using parameters such as CSF pleocytosis have been proposed in the past.”
ResultCandel, F. J., Salavert, M., Cantón, R., del Pozo, J. L., Galán‐Sánchez, F., Navarro, D., Rodríguez, A. H., Rodríguez, J. C., Rodríguez-Aguirregabiria, M., Suberviola, B., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05224-3 · Cited by 84
Vetter, P., Schibler, M., Herrmann, J. L., & Boutolleau, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.12.013 · Cited by 64
Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies
Hill, J. A. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000592 · Cited by 62
Pandey, U., Greninger, A. L., Levin, G. R., Jerome, K. R., Anand, V. C., & Dien Bard, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-20 · Cited by 61
“Contrary to recent studies that reported low incidences of meningoencephalitis despite detection of HHV-6 DNA in CSF (11, 19), we report CNS infections in 20% of all HHV-6 positive patients in this cohort.”
BackgroundResultInfluentialEichinger, A., Hagen, A., Meyer-Bühn, M., & Huebner, J. (2019) · Infection · doi:10.1007/s15010-018-1212-7 · Cited by 60
Lewinski, M. A., Alby, K., Babady, N. E., Butler‐Wu, S. M., Bard, J. D., Greninger, A. L., Hanson, K. E., Naccache, S. N., Newton, D. W., Temple‐Smolkin, R., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.08.005 · Cited by 61
Van, T. T., Kim, T. H., & Butler-Wu, S. M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.007 · Cited by 49
Boudet, A., Pantel, A., Carles, M.-J., Boclé, H., Charachon, S., Enault, C., Stéphan, R., Cadot, L., Lavigne, J.-P., & Marchandin, H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223887 · Cited by 49
“Not only HHV-6 but also CMV detections must be cautiously interpreted as both viruses are highly prevalent in the population and their amplification might correspond to primary infection, secondary reactivation or to a latent virus [23,33,34], as indicated in one of the system’s warning messages.”
BackgroundAssociation of the filmarray meningitis/encephalitis panel with clinical management
Nabower, A. M., Miller, S., Biewen, B., Lyden, E., Goodrich, N., Miller, A., Gollehon, N., Skar, G., & Snowden, J. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2019-0064 · Cited by 42
Posnakoglou, L., Siahanidou, T., Syriopoulou, V., & Michos, A. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03986-6 · Cited by 42
Hagen, A., Eichinger, A., Meyer-Buehn, M., Schober, T., & Huebner, J. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1944-2 · Cited by 41
“HHV-6positivity may represent a primary infection, a latent state of infection, a reactivation or chromosomal integration [25, 46].”
BackgroundPfefferle, S., Christner, M., Aepfelbacher, M., Lütgehetmann, M., & Rohde, H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4904-4 · Cited by 36
Beganovic, M., McCreary, E. K., Mahoney, M. V. G., Dionne, B., Green, D. A., & Timbrook, T. T. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026450 · Cited by 38
Self-citationHerpesvirus Infections of the Central Nervous System
Bharucha, T., Houlihan, C. F., & Breuer, J. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1687837 · Cited by 35
Ramchandar, N., Coufal, N. G., Warden, A. S., Briggs, B. J., Schwarz, T. M., Stinnett, R. C., Xie, H., Schlaberg, R., Foley, J., Clarke, C., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab104 · Cited by 39
“The fifth case was a positive result for HHV-6 identified by CSF PCR multiplex panel, which is of unclear clinical significance (previous studies have described FP results for this target) [24].”
BackgroundMessacar, K., Palmer, C., Gregoire, L., Elliott, A., Ackley, E., Perraillon, M. C., Tyler, K. L., & Dominguez, S. R. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.02.002 · Cited by 34
Diagnostic Testing in Central Nervous System Infection
Kanjilal, S., Cho, T. A., & Piantadosi, A. L. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1688441 · Cited by 40
“78 A few nonherpes DNA viruses can also cause CNS infection.”
BackgroundRamachandran, P., Wilson, M. R., Catho, G., Rohner, G. B., Schiess, N., Cohrs, R. J., Boutolleau, D., Burrel, S., Yoshikawa, T., Wapniarski, A. E., et al. (2021) · Viruses · doi:10.3390/v13112286 · Cited by 34
“When patient 13 was hospitalized, we initially considered a positive HHV6 result in CSF by Biofire assay to be a false positive [34,35].”
BackgroundAppropriate Use and Future Directions of Molecular Diagnostic Testing
Graf, E. H., & Pancholi, P. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-0714-5 · Cited by 31
Rapid Diagnostic Tests for Meningitis and Encephalitis—BioFire
Fleischer, E., & Aronson, P. L. (2020) · Pediatric Emergency Care · doi:10.1097/pec.0000000000002180 · Cited by 28
“This accentuates the importance of evaluating the full clinical scenario when interpreting ME Panel results.(2,25,50,60) In addition, HHV-6 can be integrated into human chromosomes and transmitted vertically giving a positive ME Panel result.”
BackgroundDistinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers
Ivaska, L., Herberg, J., & Sadarangani, M. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.01.010 · Cited by 28
Point-of-care multiplexed diagnosis of meningitis using the FilmArray® ME panel technology
Vincent, J.-J., Zandotti, C., Baron, S. A., Kandil, C., Levy, P., Drancourt, M., Raoult, D., & Ninove, L. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03859-y · Cited by 24
S2k-Leitlinie: Ambulant erworbene bakterielle Meningoenzephalitis im Erwachsenenalter
Pfister, H., & Klein, M. (2023) · DGNeurologie · doi:10.1007/s42451-023-00588-2 · Cited by 28
“Im Fall eines Nachweises von HHV-6 ist die klinische Relevanz zu prüfen (DD chromosomal integriertes HHV6 [42]).”
BackgroundWaldrop, G., Zucker, J., Boubour, A., Radmard, S., Green, D. A., & Thakur, K. T. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0380-oa · Cited by 22
Self-citationEvaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel
Humisto, A., Antikainen, J., Holma, T., Jarva, H., Toivonen, A., Loginov, R., & Mannonen, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05144-22 · Cited by 21
Slenker, A. K., Royer, T. L., & Villalobos, T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz058 · Cited by 19
Sunnerhagen, T., Widén, J., Handhal, S., & Şahin, G. Ö. (2024) · Scientific Reports · doi:10.1038/s41598-024-54621-9 · Cited by 16
Nestor, D., Thulin Hedberg, S., Lignell, M., Skovbjerg, S., Mölling, P., & Sundqvist, M. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.01.003 · Cited by 15
“A low rate of HHV-6 positivity with the FilmArray™ ME panel that could not be confirmed and/or associated with disease has been observed in previous studies (Leber et al., 2016; O'Halloran et al., 2018; Green et al., 2018) also leading to inappropriate treatment (O'Halloran et al., 2018).”
ResultMolecular Diagnostic Advances in Transplant Infectious Diseases
Young, B. A., Hanson, K. E., & Gómez, C. A. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0704-7 · Cited by 16
A Rare Case of HHV-6 Encephalitis in an Immunocompetent Host: Case Report and Literature Review
Mekheal, E., Tagliaferri, A. R., Vasquez, K. S., Pjetergjoka, R., Lobue, G., Townsend, D., Leou, K., & Singhal, M. (2022) · Cureus · doi:10.7759/cureus.23007 · Cited by 14
“Even though emphasis has been placed on careful diagnosis to avoid attributing encephalitis to a ciHHV-6 individual, clinical symptoms, exclusion of other causes, and the end results of treatment must also be considered [5].”
BackgroundWebb, G., Leong, M. Y. M., Bishop, E. J., & Sehu, M. M. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae501 · Cited by 15
Greninger, A. L., Naccache, S. N., Pannaraj, P., Jerome, K. R., Dien Bard, J., & Ruderman, J. W. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.02016-18 · Cited by 13
“This problem was evident in a recent retrospective evaluation of 15 patients, ranging in age from 27 days to 89 years, with a positive result for HHV-6 on the FilmArray M/E panel (10).”
BackgroundMilburn, J., Lechiile, K., Siamisang, K., Williams, C. G., Owen, L., Gwakuba, E., Machiya, T., Leeme, T., Barton, H. E., Doyle, R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac229 · Cited by 12
A rare case of recurrent HHV6 encephalitis in an immunocompetent adult
Al-Asmar, R., Carroll, R., Ranavaya, J., Mozahem, N., Thiesfeldt, S., & Willenburg, K. (2021) · IDCases · doi:10.1016/j.idcr.2021.e01195 · Cited by 11
“It needs the presence of appropriate clinical context, more often than not an immunosuppressed state, and significant clinical response after antiviral therapy [5].”
BackgroundThe diagnostic complexities of human herpesvirus 6 (HHV-6) infections
Gough, K. L., Anderson, T. K., Whiley, D. M., & Sweeney, E. L. (2025) · Journal of Clinical Virology · doi:10.1016/j.jcv.2025.105905 · Cited by 10
Kadambari, S., Feng, S., Liu, X., Andersson, M. I., Waterfield, R., Fodder, H., Jacquemot, A., Galal, U., Rafferty, A., Drew, R. J., et al. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004236 · Cited by 12
“In an analysis of 15 patients with a positive HHV-6 CSF PCR assay (also using the FilmArray), Green et al. 21 reported that only 1 case of HHV-6 was thought to be likely significant, in a 17-year-old HSCT patient with altered mental consciousness and seizures.”
MethodOlson, C. A., Dominguez, S. R., Miller, S. A., Chiu, C. Y., & Messacar, K. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.04.058 · Cited by 10
“Results must be interpreted cautiously, however, because qualitative DNA detection alone is insufficient evidence for active infection.(8) Clinical judgment and consideration of secondary quantitative DNA testing (in the CSF, serum and/or whole blood) is required when HHV-6 is detected in CSF on a syndromic multiplex…”
BackgroundLin, G. Y.-E., Lin, C., Chi, H., Huang, D. T., Huang, C., & Chiu, N. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.07.013 · Cited by 9
Bedoya, C. A. P., Mesa, S. E., Leal, A., Castaño, T., Bustamante, J., & Ospina, S. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062077 · Cited by 31
“5% (19) in HIV-positive ones, while in the remaining 24% (24) of the patients, the HIV status was not evaluated.”
BackgroundGuerrero, M. P., Romero, A. F., Luengas, M., Dávalos, D. M., Mesa-Monsalve, J. G., Vivas-Trochez, R., Camacho-Moreno, G., Trujillo-Valencia, M., Giraldo, J. P. C., Mejía, L. F., et al. (2022) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003637 · Cited by 8
Ganea, O. A., Tilișcan, C., Streinu-Cercel, A., Pițigoi, D., Drăgănescu, A. C., Lazar, M., Mihai, N., Florea, D., Aramă, S. Ș., & Aramă, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164660 · Cited by 7
Mori, T., Koda, Y., Kato, J., Sakurai, M., Uwamino, Y., & Hasegawa, N. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06474-5 · Cited by 7
Matthews, E., Diaz‐Arias, L. A., Beekmann, S. E., Polgreen, P. M., Waldrop, G. E., Yang, V., Rimmer, K., Venkatesan, A., & Thakur, K. T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa163 · Cited by 7
“Although the availability of a multiplex PCR panel has shown benefit in improved pathogen identification, there is also concern with overutilization in patients with low clinical suspicion for CNS infections [16, 17].”
BackgroundSelf-citationIshimaru, S., Kawamura, Y., Miura, H., Shima, S., Ueda, A., Watanabe, H., Mutoh, T., & Yoshikawa, T. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-01040-5 · Cited by 7
Wang, H., Tomatis‐Souverbielle, C., Everhart, K., Oyeniran, S. J., & Leber, A. L. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.116029 · Cited by 7
Human Herpesvirus 6 Infection and Diagnostics
Realegeno, S. E., & Pandey, U. (2022) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2022.04.005 · Cited by 6
Greninger, A. L., Naccache, S. N., Pannaraj, P. S., Jerome, K. R., Bard, J. D., & Ruderman, J. W. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.02018-18 · Cited by 6
Human herpesvirus-6 infection in a critically ill and immunocompetent patient: a case report
Chia, X. T., Wong, H. L. M., & Loh, J. S. (2024) · Journal of Medical Case Reports · doi:10.1186/s13256-024-04387-5 · Cited by 5
“For example, one study showed that HHV-6 could be detected in CSF samples from patients who were deemed clinically unlikely to have encephalitis [13].”
BackgroundChronic Lymphocytic Leukemia Infiltrating in the Brain
Webb, L. M., Kenderian, S. S., Angeli, A. M., Howard, M. T., & Wijdicks, E. F. M. (2024) · Cureus · doi:10.7759/cureus.74080 · Cited by 5
“His lack of rapid improvement with ganciclovir also argued against HHV-6 encephalitis [19].”
A Possible Case of Varicella Zoster Virus (VZV) Meningoencephalitis in an Immunocompetent Host
Goswami, S., Goyal, R., & Delury, J. (2022) · Cureus · doi:10.7759/cureus.26539 · Cited by 5
“In a study in 2018, 25% of positive meningitis/encephalitis panel results were positive for HHV-6, but the majority of these were not associated with a detectable plasma viral load; these results have been replicated [15,16].”
ResultInherited Chromosomally Integrated HHV-6: Diagnosis and Clinical Features
Miura, H., & Yoshikawa, T. (2025) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004890 · Cited by 4
Perera, M., Varadhan, H., & Oon, A. (2026) · Microbiology spectrum · doi:10.1128/spectrum.00620-25 · Cited by 4
“However, pre-analytic factors also need to be considered prior to interpretation of viral load, including WCC count, which can significantly elevate levels (9).”
Barros Domingues, R., Mendes-Correa, M. C., Vilela de Moura Leite, F. B., Vega dos Santos, M., & Senne Soares, C. A. (2022) · Pediatric Emergency Care · doi:10.1097/pec.0000000000002462 · Cited by 4
“Therefore, the HHV-6 results must be interpreted with caution, and therapeutic decisions cannot be taken based solely on the result of FilmArray ME panel.(21) Another concern regardingHHV-6 is that this virus infects peripheral blood cells and therefore may contaminate CSF in traumatic tap.”
BackgroundDetection of human herpesvirus type 6 DNA in cerebrospinal fluid is rarely clinically significant
Edén, A., Ahlin, A., Lindh, M., & Westin, J. (2025) · Journal of Clinical Virology · doi:10.1016/j.jcv.2025.105884 · Cited by 4
Acute infections of the central nervous system in children and adults: diagnosis and management
Trujillo-Gómez, J., Navarro, C. E., Atehortúa-Muñoz, S. L., & Flórez, I. D. (2024) · Minerva Medica · doi:10.23736/s0026-4806.24.09097-9 · Cited by 5
Multicenter evaluation of the FilmArray Meningitis/Encephalitis assay in a routine setting
Maelegheer, K., Reynders, M., Floré, K., Vanacker, J., Vanlaere, E., Cartuyvels, R., & Raymaekers, M. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001438 · Cited by 3
Vollmuth, Y., Soric, B., Beer, J., Behrends, U., Paolini, M., Blaschek, A., Meyer-Bühn, M., Klein, C., Hübner, J., Dobler, G., et al. (2026) · Infection · doi:10.1007/s15010-026-02811-0 · Cited by 3
“…particularly in young children, should be interpreted with caution, as it may reflect incidental viral presence including inherited chromosomally integrated HHV-6 rather than true central nervous system infection, especially in the absence of compatible clinical and laboratory findings [ 27, 28].”
Bui, N. E., Savla, P., Galvis, A. E., & Hanak, B. W. (2024) · Surgical Neurology International · doi:10.25259/sni_355_2024 · Cited by 3
“[35] However, the FA-ME panel does not distinguish between CSF samples reflecting primary infection, reactivated, or chromosomally integrated HHV-6.”
BackgroundApproche syndromique multiplexe en réanimation
Visseaux, B., & Armand-Lefèvre, L. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0109 · Cited by 4
Alramadhan, M. M., Kamdar, A. A., Lafferty-Prather, M., Aguilera, E. A., & Wootton, S. H. (2020) · Global Pediatric Health · doi:10.1177/2333794x20939759 · Cited by 3
Diagnostic Stewardship: the Central Role of Clinical Microbiology Laboratories
Green, D. A., Weidmann, M. D., & Srivastava-Malick, M. S. (2022) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2022.10.004 · Cited by 6
Self-citationTurhan, A., Kayalı, G. A., Polat, F., Çilli, F., Metin, D. Y., Ersel, M., Uslu, Ç., Saz, E. U., Pullukçu, H., Karaman, B., et al. (2025) · Mikrobiyoloji Bulteni · doi:10.5578/mb.202502145 · Cited by 2
Ibrahim, N. H., Kinsella, P. M., Chan, E., Cronin, K. M., & Bond, K. A. (2026) · Internal Medicine Journal · doi:10.1111/imj.70391 · Cited by 3
Maréchal, M. L., Diaz‐Arias, L. A., Beekmann, S. E., Polgreen, P. M., Messacar, K., Tunkel, A. R., Thakur, K. T., & Venkatesan, A. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad132 · Cited by 2
“This is particularly important given the potential for both false negatives and false positives on such testing, such as the notable example of detection of HHV-6 as a result of chromosomal integration, rather than active infection, via the BioFire assay [21].”
BackgroundSelf-citationNuaimi, M. A., Khaaldi, A. A., Trad, O., AlMulla, A. A., Rufaye, H. A., Ghatasheh, G. A., & Dhaheri, F. A. A. (2024) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002892 · Cited by 2
Persistent viremia in an immunocompetent patient with inherited chromosomally integrated HHV-6B
Obeid, M., Gakhal, I., & McDonald, P. J. (2021) · Access Microbiology · doi:10.1099/acmi.0.000256 · Cited by 2
“A retrospective study including 15 patients between 27 days to 89 years of age with a positive result for HHV-6 on the CSF PCR panels revealed low clinical probability of true HHV-6 encephalitis despite detectable HHV-6 plasma viral load in 7 of the 11 patients tested [30].”
BackgroundReal‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility
Erinmez, M., Sağlam, M., Çalışkantürk, G., Özerol, M., & Zer, Y. (2026) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/3714674 · Cited by 1
Nicolau-Guillaumet, N., Moutel, M., Plouzeau-Jayle, C., Pean de Ponfilly, G., Courbin, V., Ranc, A.-G., Revillet, H., Mourvillier, B., Hentzien, M., Muggeo, A., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00566-26 · Cited by 1
“Bacteria-positive FAME cases exhibited markedly higher CSF WBC counts than virus-pos itive cases and negative cases (median = 1,530 [2–21,000] vs 135 [2–2,300] and 17 [1– 12,700], P 0.0001).”
InfluentialAleixo, R. V., Sá, R., Ramos, I., & Valente, C. (2025) · Cureus · doi:10.7759/cureus.80780 · Cited by 1
“The potential benefit of valganciclovir in glioblastoma has been explored in small clinical studies, with some reports indicating improved survival in patients receiving antiviral therapy [2,6,13].”
Clinical Interpretation and Diagnostic Management
Gowtham, S. (2025) · Wiley eBooks · doi:10.1002/9781683674597.ch32 · Cited by 1
Novel techniques for the diagnosis of neurological infections
Alam, A. M., Houlihan, C. F., & Bharucha, T. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001395 · Cited by 1
“Furthermore, certain diagnoses which have low prevalence and questionable clinical significance outside specific sub-populations, for example HHV6, HHV7, EBV and CMV, should rely on clinical interpretation and subsequent testing to determine clinical significance (9, 10).”
McMillen, T. A., Powell, E. A., Jani, K., Scipione, M. R., Seo, S. K., & Babady, N. E. (2025) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2025.100221 · Cited by 1
“The clinical value of routine testing and consequently detection of some of the viral targets on the panel, including HHV-6 and CMV, is questionable as they may not always be associated with clinically significant disease [13,24].”
Diagnostic accuracy of laboratory methods for infectious meningitis and encephalitis
Fernandes, G. B. P., Júnior, J. D. A., Ferreira, J., Gomes, A., & Júnior, A. P. (2025) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen7779 · Cited by 2
Trentadue, T. P., Sosa, S. M., Itoh, C. Y., Modi, T., Norgan, A. P., Triplet, E. M., Santilli, A. R., Coon, E. A., & Toledano, M. (2025) · Neurology · doi:10.1212/wnl.0000000000214429 · Cited by 1
Chahid, N., Lazraq, S., Souhli, R. A., Elhassouni, M., Harrak, K. E., Tazi, E. G., Bousgheïri, F., Najdi, A., & Rissoul, K. (2026) · Cureus · doi:10.7759/cureus.110050 · Cited by 1
“Accordingly, the clinical relevance of HHV-6 detection in CSF remains controversial, highlighting the need to interpret molecular findings within the appropriate clinical context and pretest probability to avoid overdiagnosis [20,21].”
Update wichtige ZNS-Infektionen
Klein, M., Koedel, U., & Pfister, H. (2020) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0968-1063 · Cited by 1
“Die klinische Relevanz ist insbesondere bei positivem Nachweis von HHV6 infrage zu stellen – dies zeigt eine Bewertung von 15 Fällen, bei der mittels Multiplex-PCR ein positiver Nachweis von HHV6 vorlag [15]: In der genaueren Analyse der Patientendaten fand sich eine wahrscheinliche, klinisch relevante Infektion bei n…”
BackgroundNo Small Thing: Clinical Implications of Rapid Syndromic Panel-Based Diagnostic Testing in Children
NGUYEN, S., & Same, R. (2021) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2021.08.001 · Cited by 1
A Rare Case of Kleine–Levin Syndrome Following COVID-19
Shammaa, A., Shameem, A., & Amos, J. (2023) · Annals of Internal Medicine Clinical Cases · doi:10.7326/aimcc.2022.0695 · Cited by 1
Human Herpesviruses: Human Herpesvirus 6
Tesini, B. L., & Caserta, M. T. (2023) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_37-1 · Cited by 1
Fernandes, A. J., Pereira, M. J., Oliveira, Í., Novo, M., Soares, M., Ramalho, A. R., Santos, V., Vinagre, E., Lopo, S., & Gaspar, L. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004619 · Cited by 1
Self-citationLajoye, A.-L., Ciocanu, D., Duverlie, G., & Berquin, P. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02219
“Although HHV-6 meningoencephalitis is very rare in immunocompetent individual and is mainly described in hematopoietic stem cell recipients [6], the causal role of HHV-6 in meningitis in an immuno-competent patient must be considered carefully by reviewing all the clinical and laboratory data.”
Suárez-Fernández, S., Iturzaeta, A., & Rodríguez-Lucas, C. (2019) · PubMed Central
Vilca, J. G., Montesinos, D. L. C., Merizalde, W. M., Vásconez, J. H., & Villacís, V. (2021) · Revista Medica Vozandes · doi:10.48018/rmv.v31.i2.16
Human herpesvirus 6 encephalitis
Muzio, B. P. D., Sharma, R., & Bell, D. (2015) · Radiopaedia.org · doi:10.53347/rid-36613
Human Herpesviruses 6 and 7 (Roseola, Exanthem Subitum)
Nayak, J. L., & Caserta, M. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00207-x
Ji, E., Park, S. E., Oh, S. H., Chang, C. L., Lee, Y., & Kim, I. (2023) · Laboratory Medicine Online · doi:10.47429/lmo.2023.13.3.237
Atamna, A., Raphaeli, G., Dovrat, S., Grosman, A., & Bishara, J. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120824
Murphy, O. C., & Venkatesan, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00145-3
Agrawal, S. K., Goldar, S., & Neog, B. J. (2024) · Journal of Medical Evidence · doi:10.4103/jme.jme_135_23
Pershad, J., Crawford, L. M., Preciado, D. A., Harrar, D. B., Molto, J., & Shapiro, C. A. (2024) · The Journal of Pediatrics Clinical Practice · doi:10.1016/j.jpedcp.2024.200123
Human Herpesviruses 6A, 6B, and 7
Greninger, A. L., Sedlak, R. H., & Jerome, K. R. (2023) · Wiley eBooks · doi:10.1002/9781683674849.mcm0105
Couturier, M. R., Raible, K. M., Cintrón, M., Babady, N. E., Bard, J. D., & Van, T. T. (2023) · Wiley eBooks · doi:10.1002/9781683670438.cmph0155
Human Herpesviruses 6A, 6B, and 7
Greninger, A. L., Sedlak, R. H., & Jerome, K. R. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0105
Leber, A. L., Oyeniran, S. J., & Wang, H. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae164
Clinical Interpretation of Ultrasensitive Molecular Assays
Ortiz, D. A., & Buchan, B. W. (2025) · Wiley eBooks · doi:10.1002/9781683674597.ch31
Wagle, L., Aryal, E., Timshina, A., Griffin, C., Santhekadur, P., & Poudel, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5385357
Metadata
- Authors
- Green, D. A., Pereira, M., Miko, B., Radmard, S., Whittier, S., & Thakur, K.
- Affiliations
- Department of Pathology & Cell Biology, New York, New York
- Division of Infectious Diseases, New York, New York
- Columbia University Irving Medical Center (US)
- Corresponding author
- Green, Daniel A
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-09
- Volume
- 67
- Issue
- 7
- Pages
- 1125-1128
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7108106
- OpenAlex
- W2797860862
- Cited by
- 110
- References
- 24
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 17 · 2023: 12 · 2022: 9 · 2021: 11 · 2020: 13 · 2019: 16 · 2018: 2
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (K23NS105935)
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- human herpesvirus 6, HHV-6 encephalitis, FilmArray Meningitis/Encephalitis panel, molecular diagnosis, diagnostic test interpretation, false positives, herpesvirus infection
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Middle Aged, Herpesvirus 6, Human, Immunocompromised Host, Encephalitis, Viral, Roseolovirus Infections, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.